Phenylbutyrate for STXBP1 Encephalopathy – A Pilot Study

Awardee: Zachary Grinspan

Institution: Weill Cornell Medicine

Grant Amount: $69,588

Previous
Previous

Rapid and unbiased in vivo screen for lead compounds that rescue STXBP1 dysfunction and subsequent in vitro validation in human neurons

Next
Next

Towards new therapeutic treatments for the hyperinsulinism/hyperammonemia syndrome (HI/HA)